Lv42
520 积分 2022-09-15 加入
Machine learning for functional protein design
1天前
已完结
Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor
4个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
4个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
4个月前
已完结
Humanization of Camelid Single-Domain Antibodies
5个月前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
5个月前
已完结
Designed endocytosis-inducing proteins degrade targets and amplify signals
6个月前
已完结
New immune cell engagers for cancer immunotherapy
7个月前
已完结
The present and future of bispecific antibodies for cancer therapy
7个月前
已完结
T-cell-engaging bispecific antibodies in cancer
9个月前
已完结
皖公网安备34019202002308
